William Spanogle

Sr Director: Product & Process Development (Regulated Life Sciences) at Biotechresearchgroup.com (BRG)

Role
Sr Director Product Development (Regulated Life Sciences) at Biotech Research Group
Location
Philadelphia, PA, US
LinkedIn followers
500 followers

About William Spanogle

FDA and International expert across the full spectrum of Regulatory Life Sciences & scope of the Product Lifecycle. Proven expert: Pre-IND/BLA/QSub Mtg, CMC-Risk-QMM-Submissions-Registration bringing scores of Products/Processes from Discovery - Phase 4 EUAs, PIND, IND, NDAs, ANDA, 510(k), De Novo, NCE/NME, Combination Products, BLA, PAIs, etc. Proven Science-Risk-Data Driven Full Product Lifecycle Go-To leader, expert, and Invitational Author/Presenter/Mentor in QbD Characterization, BREXIT-UKCA Process, Design Controls, EU-MDR/IVDR 2017. Risk Mgt (2019) Benefit Analyses, CARES, CSA/CMMI, CSV, GAMP 5, RDI, Design & Tech Transfer, Data Integrity, eCTD- Module 1-5 CMC, 510(k), BLA, PAI, Clin Trials & Supplies, CER, GCP, GLP, FA-Complaints-PMS-Design Controls, & Digital Trans. As Sr Director at https://biotechresearchgroup.com/, Provide Product & Process Development Core Regulatory Affairs Services, Submissions, and US Agent/Interface with FDA, EU, UK, TGA, Canada, Japan, WHO, DOD, and all other International Regulatory Bodies. Proven go-to executive, adviser and leader for C-Suite & All-Levels via Hands-On Regulated Life Sciences Service and Deliverables. I adhere to, design, & implement Current USA & Global Life Science Regulations to bring scores of Biologics, Biotech, Stem-NK-T cells, GTx, Antagonists, Med Dev, OTC, Combo Products, Early Discovery, First In Humans, Clinical Trials, Scale Up, and Tech/Methods Transfer to Commercialization. • FDA & EU-MDR Submissions, eCTD Mod 1-5, 510(k), 21CFRs, ICHQ1-Q12, ISO 13•••16 & 14•••••19, MHRA-17, QMM. • ISPE PQLI QbD Invitational Author Guide 1 & 2 https://ispe.org/sites • SVMPs, RMPs & Remediation, LOAEL - NOAEL - ALCOA+ • Val - Qual Compliance Assessments, Audits, Resolutions • GO TO PROBLEM SOLVER & LEADER: mentoring relationships: Individuals, Teams, Groups, Companies: • CAPA, Investigations, Change Mgt, Control, Complaints, Data Integrity • CD Remediation, Submissions, CBE30, APRs • Six-Sigma, DMAIC, GAMP, CSV/CSA, RDI, IOPQ • Innovate-Compliant Breakthroughs • SOPs, MBRs, Test Methods (ALL ASPECTS) • IV, Needle Free, Transdermal Delivery, Troubleshooting • GMP, EU & QSR Operations, RA & QS Turnarounds • Aseptic-Sterilization Proc-Pack-Seal • SQM, SQA, PV, MSA, QTA • ISO 63204 Part 11, CSV/CfQ/CSA, GAMP • Multi-Prod\'t Facilities • 3rd Party Relationships • Containment, Cleaning, EM * ASQ-CQE #20186 * ASQ-CSQE #740 * ASQ-FDA Invited Spkr - GMP CSV/CfQ/CSA * FDA Certified HACCP FMEA Facilitator (ISO 14971)* ICH Q1-Q12, USP, PhEur * Certified Covey 7 Habits Facilitator & Principle Centered Leadership

Experience

  1. Sr Director Product Development (Regulated Life Sciences)

    Biotech Research Group

    Oct 2020 — Present

    RA Agent, Write, Review, Submit-FDA & Global, Characterization (ICH Q1-12, QbD), 510(k), Predicates, CMC, eCopy, ESG, ESS, eCTD, IND, NDA, ANADA, INAD, JINAD, NADA, ANADA, CNADA, Supply Chain, Investigations & Root Cause, QMS, Inspection Readiness, & Full Spectrum of ALL related Regulated Life Sciences Products, Processes, and Regulations, PV, AR, PADER, MAH. • Med Dev, SaMD-AI, & Combo Prod\'t: Science-Risk Based RA Strategy & Rapid 510(k), Design Controls, GMPs, EU-MDR/IVDR 2017 & Infrastructure, Clinical Evaluation Plan & Report, Pre Market Requirements, Post Market Reqts (PMS, PMCF, Risk Management Product Life Cycle), 510(k) or De Novo Submissions, IDE, PMAs, Classification, Registration, listing, recalls, Import/Export, FDA Communications, 513(g) Request for Information, HUD/HDE Submissions • Pharmaceuticals (Rx, Tx, OTC): Science-Risk Based RA Strategy and Rapid CMC, FDA Briefing Package, Pre-IND Meeting, FDA communications and meetings Discovery through Phase IV, Clinical Trial Coordination & GCPs, QMS-GMPs, Pilot Plants, Scale Up, SVMP, CMOs, QTAs, Orphan Drugs, Literature & Scientific Research Reviews, 505(b)2, CBE-30 & 21CFR314, 513(g) Request for Information, ANDA suitability, Technical File Content, Review & CMC, Global Regulation Interpretation and Implementation • Biologics: Science-Risk Based RA Strategy and Rapid CMC, Pre-Clinical testing & verification, Clinical Trial Coordination & GCPs, Pharm/Tox, TQM-QMS, Biologics Manufacturing (Aseptic/Sterility), Pilot Plants, Scale Up, SVMP, Suppliers, CMOs, QTAs, GTPs, GMPs, GLPs, SOPs, BLAs and PMIs. • Quality & Compliance: QMS, CSA/CSV, Part 11, RDI, SOPs (Dev, red line, implementation, training), All GxP Training, Mock FDA Inspection & Readiness, Vendor Audits, Vendor Selection Assessments/Remediations, 483/WL/CD Remediation, SVMP, Clean Rooms & Sterility, Recalls, Adverse Event-Deviations-CAPA Root Cause ID & Remediation, FDA & Global Regulations QMS Regulations. • Regulatory Litigation Expertise.

Education

  • Utah State University

    MS Degree, Plant Science: Genetic Eng, Comp Sci & Stats

  • Colorado State University

    BS Degree, Wildlife Biology - Cum Laude

  • Kansas State University

    Ph.D., Agronomy: Genetic Engineering, Comp Sci & Stats

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

William Spanogle — Sr Director Product Development (Regulated Life Sciences) at Biotech Research Group in Philadelphia, PA, US | Unifers